FR2924430B1 - Procede de preparation de nanoparticules a base de molecules ou macromolecules amphiphiles fonctionnelles et leur utilisation - Google Patents
Procede de preparation de nanoparticules a base de molecules ou macromolecules amphiphiles fonctionnelles et leur utilisationInfo
- Publication number
- FR2924430B1 FR2924430B1 FR0708399A FR0708399A FR2924430B1 FR 2924430 B1 FR2924430 B1 FR 2924430B1 FR 0708399 A FR0708399 A FR 0708399A FR 0708399 A FR0708399 A FR 0708399A FR 2924430 B1 FR2924430 B1 FR 2924430B1
- Authority
- FR
- France
- Prior art keywords
- macromolecules
- preparation
- amphiphilic molecules
- nanoparticles based
- functional amphiphilic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/242—Gold; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0708399A FR2924430B1 (fr) | 2007-11-30 | 2007-11-30 | Procede de preparation de nanoparticules a base de molecules ou macromolecules amphiphiles fonctionnelles et leur utilisation |
US12/745,670 US20110059180A1 (en) | 2007-11-30 | 2008-11-28 | Method for Preparing Nanoparticles Based on Functional Amphiphilic Molecules or Macromolecules, and the Use Thereof |
EP08872219A EP2231132A2 (fr) | 2007-11-30 | 2008-11-28 | Procédé de préparation de nanoparticules à base de molécules ou macromolécules amphiphiles fonctionnelles et leur utilisation |
PCT/FR2008/001661 WO2009098404A2 (fr) | 2007-11-30 | 2008-11-28 | Procédé de préparation de nanoparticules à base de molécules ou macromolécules amphiphiles fonctionnelles et leur utilisation |
JP2010535425A JP5719594B2 (ja) | 2007-11-30 | 2008-11-28 | 機能性両親媒性の分子又は巨大分子を基とするナノ粒子の調製方法及びその使用 |
CN2008801260085A CN101932310B (zh) | 2007-11-30 | 2008-11-28 | 制备基于官能两亲分子或者大分子的纳米颗粒的方法和其用途 |
CA2706812A CA2706812A1 (fr) | 2007-11-30 | 2008-11-28 | Procede de preparation de nanoparticules a base de molecules ou macromolecules amphiphiles fonctionnelles et leur utilisation |
US14/208,978 US9533049B2 (en) | 2007-11-30 | 2014-03-13 | Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof |
JP2014198816A JP2015044815A (ja) | 2007-11-30 | 2014-09-29 | 機能性両親媒性の分子又は巨大分子を基とするナノ粒子の調製方法及びその使用 |
JP2016149551A JP6280167B2 (ja) | 2007-11-30 | 2016-07-29 | 機能性両親媒性の分子又は巨大分子を基とするナノ粒子の調製方法及びその使用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0708399A FR2924430B1 (fr) | 2007-11-30 | 2007-11-30 | Procede de preparation de nanoparticules a base de molecules ou macromolecules amphiphiles fonctionnelles et leur utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2924430A1 FR2924430A1 (fr) | 2009-06-05 |
FR2924430B1 true FR2924430B1 (fr) | 2010-03-19 |
Family
ID=39638675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0708399A Expired - Fee Related FR2924430B1 (fr) | 2007-11-30 | 2007-11-30 | Procede de preparation de nanoparticules a base de molecules ou macromolecules amphiphiles fonctionnelles et leur utilisation |
Country Status (7)
Country | Link |
---|---|
US (2) | US20110059180A1 (fr) |
EP (1) | EP2231132A2 (fr) |
JP (3) | JP5719594B2 (fr) |
CN (1) | CN101932310B (fr) |
CA (1) | CA2706812A1 (fr) |
FR (1) | FR2924430B1 (fr) |
WO (1) | WO2009098404A2 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2945946B1 (fr) * | 2009-05-29 | 2011-08-26 | Univ Victor Segalen Bordeaux 2 | Formulations a compartiments multiples a base de molecules ou macromolecules amphiphiles fonctionnelles |
EP3085360A1 (fr) | 2015-04-20 | 2016-10-26 | Universite De Bordeaux | Compositions de nanovecteurs à base de lipide chargées avec des nanoparticules métalliques et agent thérapeutique |
JP2019532027A (ja) | 2016-08-17 | 2019-11-07 | ソルスティス バイオロジクス,リミティッド | ポリヌクレオチド構築物 |
EP3645546A4 (fr) | 2017-06-30 | 2021-12-01 | Solstice Biologics, Ltd. | Auxiliaires de phosphoramidites chiraux et leurs procédés d'utilisation |
EP3502684A1 (fr) | 2017-12-22 | 2019-06-26 | Universite De Bordeaux | Procédé de détection d'ions métalliques dans des solutions aqueuses au moyen de composés nucléolipides |
EP3505178A1 (fr) | 2017-12-29 | 2019-07-03 | Universite De Bordeaux | Formulations de gel de bio-encres comprenant un composé à base de nucléolipides |
FR3078064A1 (fr) | 2018-02-22 | 2019-08-23 | Universite de Bordeaux | Procede de decontamination d'un milieu liquide aqueux contenant des micropolluants |
EP4013740A4 (fr) * | 2019-08-12 | 2023-09-20 | Integrated Nanotherapeutics Inc. | Lipides pour l'administration d'un matériau chargé, leurs formulations et leur procédé de fabrication |
WO2024125556A1 (fr) * | 2022-12-13 | 2024-06-20 | 上海拓界生物医药科技有限公司 | Oligonucléotide comprenant un monomère lipophile et son utilisation dans le cadre d'une délivrance non hépatique |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0696590B2 (ja) * | 1985-04-16 | 1994-11-30 | 富山化学工業株式会社 | 新規な5−フルオロ−2′−デオキシウリジン−3′−ホスフエ−ト誘導体およびその塩 |
DK86988A (da) * | 1987-02-25 | 1988-08-26 | Takeda Chemical Industries Ltd | Liposompraeparat og anvendelse deraf |
US6001817A (en) * | 1998-01-12 | 1999-12-14 | Unitech Pharmaceuticals, Inc. | Pharmaceutical composition comprised of cisplatin, and processes for making and using same |
GB9813535D0 (en) * | 1998-06-23 | 1998-08-19 | Glaxo Group Ltd | Chemical compounds |
WO2001032139A2 (fr) * | 1999-11-05 | 2001-05-10 | Seed Capital Investment-2 (Sci-2) B.V. | Procede de formulation de substances a hydrosolubilite et lipophilie faibles et formulation ainsi obtenue |
AU2002359918A1 (en) * | 2001-12-28 | 2003-07-24 | Terumo Kabushiki Kaisha | Blood bag system and method of inactivating pathogenic microorganisms |
FR2869616B1 (fr) * | 2004-04-29 | 2008-10-24 | Univ D Avignon Et Des Pays Du | Nouveaux composes amphiphiles, leur procede de preparation et leurs applications notamment a la transfection |
CN103735560A (zh) * | 2005-06-07 | 2014-04-23 | 耶鲁大学 | 使用克来夫定和替比夫定治疗癌症和其它病症或疾病状态的方法 |
FR2945946B1 (fr) * | 2009-05-29 | 2011-08-26 | Univ Victor Segalen Bordeaux 2 | Formulations a compartiments multiples a base de molecules ou macromolecules amphiphiles fonctionnelles |
-
2007
- 2007-11-30 FR FR0708399A patent/FR2924430B1/fr not_active Expired - Fee Related
-
2008
- 2008-11-28 CN CN2008801260085A patent/CN101932310B/zh not_active Expired - Fee Related
- 2008-11-28 WO PCT/FR2008/001661 patent/WO2009098404A2/fr active Application Filing
- 2008-11-28 EP EP08872219A patent/EP2231132A2/fr not_active Withdrawn
- 2008-11-28 CA CA2706812A patent/CA2706812A1/fr not_active Abandoned
- 2008-11-28 US US12/745,670 patent/US20110059180A1/en not_active Abandoned
- 2008-11-28 JP JP2010535425A patent/JP5719594B2/ja not_active Expired - Fee Related
-
2014
- 2014-03-13 US US14/208,978 patent/US9533049B2/en not_active Expired - Fee Related
- 2014-09-29 JP JP2014198816A patent/JP2015044815A/ja active Pending
-
2016
- 2016-07-29 JP JP2016149551A patent/JP6280167B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2015044815A (ja) | 2015-03-12 |
JP2017014243A (ja) | 2017-01-19 |
EP2231132A2 (fr) | 2010-09-29 |
US20140308343A1 (en) | 2014-10-16 |
JP2011504920A (ja) | 2011-02-17 |
WO2009098404A2 (fr) | 2009-08-13 |
JP6280167B2 (ja) | 2018-02-14 |
JP5719594B2 (ja) | 2015-05-20 |
WO2009098404A3 (fr) | 2009-11-12 |
FR2924430A1 (fr) | 2009-06-05 |
WO2009098404A8 (fr) | 2010-01-28 |
US20110059180A1 (en) | 2011-03-10 |
CN101932310B (zh) | 2013-11-13 |
CN101932310A (zh) | 2010-12-29 |
US9533049B2 (en) | 2017-01-03 |
CA2706812A1 (fr) | 2009-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2924430B1 (fr) | Procede de preparation de nanoparticules a base de molecules ou macromolecules amphiphiles fonctionnelles et leur utilisation | |
LTPA2019504I1 (lt) | Pagerintos TM nanodalelės, skirtos agregacijos sąlygotų sutrikimų gydymui | |
BRPI1010648A2 (pt) | métodos para o diagnóstico de distúrbios oncológicos usando transferidores epimetabólicos, moléculas intracelulares multidimensionais ou influenciadores ambientais | |
EP2245135A4 (fr) | Dispositifs d'analyse de petites molécules et de protéines à partir de polymères à empreintes moléculaires | |
CY2016053I1 (el) | Μεθοδοι αγωγης χρησιμοποιωντας φαρμακευτικες ουσιες συλληψης αμμωνιας | |
IL202883A (en) | N - (2 - (taryl) aryl) aryl sulfonamides and n - (2 - (taryl) taryl) aryl sulfonamides, pharmaceutical preparations containing them and their uses | |
IL212568A (en) | Annotated 4,1-Diazepan, Pharmaceutical Preparations Containing Them and Their Uses in the Preparation of Medicines for the Treatment of Diseases or Disorders of Mammals | |
IL221160A (en) | 4,2,1-triazine-3-amine derivatives, a process for their preparation and use for drug preparation | |
EP2197575A4 (fr) | Gels polymères liés à de l'argile dans de nouvelles formes physiques, leurs procédés de formation et leurs utilisations | |
FI20075062A0 (fi) | Menetelmä, laite, järjestelmä, tietokoneohjelmatuote ja tietokoneohjelman jakeluväline | |
BR112012016882A2 (pt) | "monólitos de polímero poroso, processos para preparação e uso dos mesmos" | |
BR112013032803A8 (pt) | "derivados de n-[(1h-pirazol-1-il)aril]-1h-indol ou 1h-indazol-3-carboxamida, sua preparação e aplicação dos mesmos em terapêuticos" | |
IT1391734B1 (it) | Nuovi biomateriali, loro preparazione per elettrospinning e loro uso in campo biomedico e chirurgico. | |
FR2945946B1 (fr) | Formulations a compartiments multiples a base de molecules ou macromolecules amphiphiles fonctionnelles | |
FR2895412B1 (fr) | Procede de preparation de nanoparticules en feuillets et nanoparticules obtenues. | |
ATE520658T1 (de) | Neue diazeniumdiolat-derivate, ihr herstellungsverfahren und sie enthaltende pharmazeutische zusammensetzungen | |
FR2912648B1 (fr) | Dispersion de particules de polymere, composition la comprenant et procede de traitement cosmetique | |
EP2167468A4 (fr) | Procédé de préparation et formulations pharmaceutique de 4-quinolinones et quinoléines et utilisation de celles-ci | |
DE602007007347D1 (de) | Modifizierte anorganische Partikel und Verfahren zu deren Herstellung | |
DE602006019302D1 (de) | Organosilicium-polymer und verfahren zu dessen herstellung | |
FR2992197B1 (fr) | Composition cosmetique comprenant des particules diffusantes non interferentielles et des particules d'aerogel, et procede cosmetique d'eclaircissement | |
BRPI0915558A2 (pt) | compostos anticancerígenos, processo de preparo destes, uso dos mesmos, medicamento e composição farmacêutica | |
FR2880821B1 (fr) | Emulsions aqueuses de polyacrylates, leur procede de preparation et leur utilisation dans le domaine petrolier | |
ATE481393T1 (de) | Neue cycloalkyl-benzothiadiazin-derivate, ihr herstellungsverfahren und die pharmazeutischen zusammensetzungen, die sie enthalten | |
FR2912649B1 (fr) | Dispersion de particules de polymere, composition la comprenant et procede de traitement cosmetique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 9 |
|
PLFP | Fee payment |
Year of fee payment: 10 |
|
ST | Notification of lapse |
Effective date: 20180731 |